Advanced Wound Management Market Snapshot
As per a Future Market Insights (FMI) market survey, surging cases of burn wounds, traumatic injuries, and chronic ulcers are underpinning the need for development of effective wound management products globally.
After overcoming the initial impacts of the COVID-19 outbreak, the advanced wound management market is projected to grow at a steady pace, exceeding a market valuation of US$ 6.5 Bn between 2021 and 2031.
Key Points Covered in Advanced Wound Management Market Survey
- Market estimates and forecast 2021-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Advanced Wound Management and how to Navigate
- Recommendation on Key Winning Strategies
Advanced Wound Management Market Historic Sales Compared to 2021-2031 Forecast Outlook
Sales in the advanced wound management market increased at 4.5% CAGR from 2016 to 2020. Investments in research and development activities by key market players have helped in shaping the demand outlook positively.
However, temporary suspension of these efforts amid pandemic outbreak in 2020 and prioritization of COVID-19 patients during this time temporarily restricted growth. Nevertheless, FMI has projected recovery in the coming years as healthcare sector gradually returns to its normal course.
According to the report, the rising cases of road accidents, unprecedented injuries, and diabetic foot ulcers are among the common causes pushing the demand for advanced wound management. These factors are likely to augment growth, facilitating expansion at approximately 6.5% CAGR through 2031.
Will Alginate Become a Key Ingredient in Advanced Wound Dressing?
Despite being a therapeutic healing process, wound dressing comprises common problems associated with materials used, which might cause inabilities in wound healing in some cases.
Inefficacies including improper moist environment, poor absorption of wound treatment agents, interrupted gas exchange between the wound and the environment, lack of protection against bacterial infection, and non-sterile allergic reaction delay the wound healing process in different injuries.
Unique properties associated with alginate have catapulted it to the fore, as a potential biopolymer that can effectively accelerate the wound healing process. Biocompatibility and non-toxicity of alginates are driving its applications in the field of biomedicine.
Alginate is widely being adopted in wound dressings as it potentially enhances absorption of wound exudates and minimizes bacterial infections. It also has hemostatic properties which are useful in open, bleeding wounds and can be tailored to materials that are suitable for advanced wound management.
Owing to these factors, alginate is being used to prepare different forms of wound dressing materials including hydrogels, wafers, foams, nanofibers, films, and topical formulations. As therapeutic efficacy of alginates has effectively influenced applications in advanced wound management, sales are anticipated to witness an uptick during the forecast period, opines FMI.
Silver Finding Applications in Advanced Wound Management?
While silver metal has no biomedical properties, silver ion (Ag+) possesses a broad antimicrobial spectrum and is toxic to bacteria, viruses, yeast, and fungi, leading to applications in advanced wound management.
Increasing research and development in the healthcare sector have renewed the interest in silver as a topical antimicrobial agent. Silver sulfadiazine (SSD) is being actively used in silver formulations to treat burn wounds, and recent development in nanocrystalline silver are being observed.
Although silver has commendable antimicrobial and anti-bacterial properties, injudicious use of silver in wound treatment formulations leads to impaired wound healing. Therefore, it is imperative to abide by the guidelines issued for cautious use of silver-containing dressings.
Silver-containing dressings more effectively reduce cost of treatment, promote epithelialization and prevent toxic infections in the wound. Taking cues from these factors, market players are investing heavily in research and development to develop effective silver-containing dressing to improve sales.
Negative Pressure Wound Therapy To Gain Momentum for Diabetic Foot Ulcers Treatment
Negative pressure wound therapy (NPWT) devices have been a breakthrough in wound care over the last decade. NPWT has a significant impact on wound salvage, which is further boosting its applications in multidisciplinary settings for the management of diabetic foot ulcers.
As per the World Health Organizations (WHO), 422 million people suffer from diabetes, out of which 15-20% of patients are likely to develop foot ulcers in their lifetime. Diabetic foot ulcers are a great challenge for surgeons as they are difficult to heal, leading to foot amputations in some cases while being a huge financial burden for patients.
NPWT is used in post-debridement wounds, foot abscesses, infective heal ulcers, and exposed bones and tendons. Developments in NPWT are still evolving, wherein incorporation of nanocrystalline antimicrobials is further improving wound healing outcomes.
The positive outcomes of NPWT in chronic wounds treatment are associated with removal of interstitial fluid, reduction in bacterial colonization, increase in vascularity, and stimulation of tissue formation.
Recent developments in NPWT include portable devices and home-care protocols that are helping expand NPWT’s usage beyond hospitals and clinics.
Country-wise Insights
How Will the Advanced Wound Management Market Expand Across the U.S.?
As per FMI’s analysis, the U.S. is anticipated to exhibit wound management demand uptick. Rising cases of chronic, surgical, and traumatic wounds in the country, along with increasing technological advancements in the healthcare sector are chief factors shaping the demand outlook.
In 2020, the Centers for Disease Control and Prevention (CDC) reported 34.2 million cases of diabetes in the U.S. These numbers are underscoring the need for efficient wound care for patients with diabetic foot ulcers, leading to development of new technologies in advanced wound management.
Apart from this, government-backed investments and increasing per capita expenditure in the U.S. are anticipated to drive market growth through 2031.
Why Will the U.K. Exhibit High Demand for Advanced Wound Management?
Increasing awareness regarding effective wound management materials in the U.K. is projected to drive market growth. Besides this, presence of leading players such as Smith & Nephew Plc Convatec Group will continue boosting product innovations in the market.
Apart from diabetes, incidence of breast cancer in the U.K. is on a rise. With breast surgical procedures becoming more frequent and complex, a pressing need for advanced wound management has emerged in the country.
Preference for risk-reducing surgeries such as bilateral prophylactic mastectomy is widely being observed among patients. These surgeries result in wounds and scarring that require optimal care and healing.
To overcome these challenges, UK-based Smith and Nephew Plc launched PICO 7Y in 2018, a single-use negative wound therapy system (sNWPT) with AIRLOCK system. PICO is the first sNPWT device that includes an integrated Y extension allowing it to address two wounds at the same time.
The new technology enables utilization of two dressings through a single pump, thereby reducing the cost of care significantly. Such developments are expected to lay the groundwork for market expansion in the country during the assessment period.
Will China Emerge as a Lucrative Market?
Growing geriatric population in China is resulting in increasing incidence of lifestyle-related health disorders and chronic wounds, thereby creating need for advanced wound management.
Longer life expectancy and declining fertility rates in China are likely to expand the geriatric population in the country, which as per the WHO will account for 28% of the total population by 2040. These shifting demographics have led to advancements in the healthcare sector in China such as public health insurance schemes and reimbursements for medical products.
Owing to such development, advanced wound management market is poised to witness high growth in China. Novel wound treatments targeting wound closure, debridement, cleansing, and infection control will continue gaining momentum in the upcoming decade.
Apart from this, sales of advanced wound management products including hemostatic agents, robotic surgery devices, tissue-engineered skin grafting agents, and post-surgery wound care topical treatment are projected to rise, further augmenting the market growth.
India Set to Exhibit High Demand for Advanced Wound Management
Road accidents have become a major social burden in India. As per reports published by the Ministry of State Road Transports & Highways, 449,002 road accidents took place in 2019, leading to 151,113 deaths and 451,461 injuries.
Concerns regarding road accident injuries and other chronic injuries among the Indian population has led to superior advancements in the healthcare sector. Effective treatment strategies for traumatic wounds and burn wounds are becoming the need of the hour in India.
Besides this, increasing cases of chronic ulcers is pushing demand for advanced wound management in India. Government investments in the healthcare sector, along with academic research surrounding advanced wound treatment products will continue fostering sales in the market through 2031.
Category-wise Insights
Advanced Wound Dressings to Remain Dominant Product Type
Based on product type, advanced wound dressings are anticipated to account for maximum sales. Increasing applications of advanced wound dressings for management of ulcers, traumatic injuries, burns, and invasive surgeries will push demand in the market.
In addition, developments of products such as hydrogels, alginate, silver-containing topical ointments, and collagen will provide tailwinds to sales through 2031.
Chronic Ulcers To Account for Maximum Applications
Chronic ulcers, particularly diabetic foot ulcers are unresponsive to initial treatment and appropriate care, further resulting in amputations. With increasing number of diabetic patients globally, incidence of chronic ulcers is expected to rise.
As chronic ulcers negatively impact the quality of life and represent a financial burden on the healthcare sector, advancements in wound management systems are anticipated to witness growth.
Applications of collagen, biological dressings, platelet-rich plasma, silver products, and negative pressure wound therapy (NPWT) are clinically proven to assist wound healing, which in turn is boosting sales in advanced wound management market.
Hospitals to Lead End-User Segment, Followed By Clinics
FMI projects hospitals to dominate the end-user segment between 2020 to 2031. Appropriate application of advanced wound treatment products, constant wound assessment, and active patient care in hospitals makes them largely preferred among patients and healthcare professionals.
Besides this, applications of advanced wound treatment products in specialized clinics will gain traction in the upcoming years. Reachability, cost of care, and convenience are some factors that largely influence patients' preferences for clinics. Such factors are likely to boost applications of advanced wound treatments in clinics.
Competitive Landscape
According to FMI’s market survey, the advanced wound management market comprises major players such as Convatec Group Plc, 3M Health Care, B. Braun Melsungen AG, and Acelity L.P. Inc., accounting for nearly 3/4th of the total market share.
As a part of their growth strategies, leading players in the advanced wound management market are focusing on product developments, approvals, strategic partnerships, and acquisitions to strengthen their position in the market. For instance:
- In March 2021, B. Braun Avitum AG, a global manufacturer of medical devices and pharmaceutical products collaborated with CytoSorbents Corporation, a critical care immunotherapy leader. The collaboration was aimed to promote a global co-marketing agreement regarding sales of CytoSorb blood purification technology to treat inflammation.
- In January 2020, ConvaTec Group Plc, announced the release of its new ConvaMax superabsorber wound dressing. ConvaMax superabsorber dressing is applied in highly exuding wounds such as leg ulcers, diabetic foot ulcers, pressure ulcers, and surgical wounds.
Scope of Report
| Attribute | Details |
| Forecast Period | 2021-2031 |
| Historical Data Available for | 2016-2020 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa
|
| Key Countries Covered | US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Segments Covered | Product Type, Application Type, End-Users Type, and Regions |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Key Questions Answered in the Report
-
What is the current Advanced Wound Management market value?
The advanced wound management market reached a valuation of US$ 6.5 Bn in 2021.
-
At what rate did the Advanced Wound Management market grow between 2016 and 2020?
The advanced wound management market experienced healthy growth, exhibiting a 4.5% CAGR between 2016 and 2020.
-
What are the key trends driving Advanced Wound Management sales?
Rising cases of chronic wounds and diabetic foot ulcers, coupled with product developments by leading players are key factors driving sales in the advanced wound management market.
-
Who are the leading players in the Advanced Wound Management market?
Leading players operating in the advanced wound management market include ConvaTec Group Plc. Coloplast A/S, Molnlycke Health Care AB, 3M Healthcare, and Smith & Nephew PLC.
-
What will be the demand outlook for North America Advanced Wound Management market?
North America advanced wound management market is anticipated to witness high growth during the forecast period.
-
What will be the Advanced Wound Management market share in Europe?
The advanced wound Management market in Europe is expected to grow at a steady pace, with the U.K. accounting for maximum market share.
Advanced Wound Management Market by Category
By Product Type:
- Advanced wound dressings
- Alginates
- Collagens
- Films
- Foams
- Hydrocolloids
- Hydrofibers
- Hydrogels
- Wound contact layers
- Superabsorbent dressings
- Negative pressure wound therapy devices
- Standalone NPWT devices
- Portable NPWT devices
- Single-use disposable NPWT devices
- NPWT accessories
By Application Type:
- Chronic ulcers
- Venous leg ulcers
- Diabetic foot ulcers
- Pressure ulcers
- Non-healing surgical wounds
- Traumatic wounds
- Burn cases
By End-User Type:
- Hospitals
- Clinics
- Ambulatory surgical centers
- Skilled nursing facilities
By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- Asia Pacific Excluding China (APEC)
- China
- Middle East & Africa (MEA)
Need specific information?
In the news
by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights
Talk Show:
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
Our Clients
View Our Reports from Healthcare
View Reports